ATE338125T1 - Galectin aus milben - Google Patents

Galectin aus milben

Info

Publication number
ATE338125T1
ATE338125T1 AT03707178T AT03707178T ATE338125T1 AT E338125 T1 ATE338125 T1 AT E338125T1 AT 03707178 T AT03707178 T AT 03707178T AT 03707178 T AT03707178 T AT 03707178T AT E338125 T1 ATE338125 T1 AT E338125T1
Authority
AT
Austria
Prior art keywords
galectin
polynucleotide
vector
fever
mites
Prior art date
Application number
AT03707178T
Other languages
English (en)
Inventor
Kozo Fujisaki
Hideyuki Nagasawa
Ikuo Igarashi
Hiroshi Suzuki
Chichiro Sugimoto
Gakunan Gen
Noboru Inoue
Naoaki Yokoyama
Naotoshi Tsuji
Original Assignee
Meiji Seika Kaisha
Kozo Fujisaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha, Kozo Fujisaki filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE338125T1 publication Critical patent/ATE338125T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Insects & Arthropods (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03707178T 2002-02-28 2003-02-28 Galectin aus milben ATE338125T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002053146 2002-02-28

Publications (1)

Publication Number Publication Date
ATE338125T1 true ATE338125T1 (de) 2006-09-15

Family

ID=27764351

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03707178T ATE338125T1 (de) 2002-02-28 2003-02-28 Galectin aus milben

Country Status (9)

Country Link
US (3) US7135552B2 (de)
EP (1) EP1479773B8 (de)
JP (1) JP4300117B2 (de)
AT (1) ATE338125T1 (de)
AU (1) AU2003211361B8 (de)
BR (1) BR0303322A (de)
DE (1) DE60307987T8 (de)
NZ (1) NZ535468A (de)
WO (1) WO2003072781A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1479773B8 (de) * 2002-02-28 2007-02-14 Meiji Seika Kaisha Ltd. Galectin aus milben
JP4719527B2 (ja) * 2005-08-03 2011-07-06 独立行政法人農業・食品産業技術総合研究機構 ベクターマダニのガレクチン、それをコードする核酸分子及びそれらの利用
WO2011100528A2 (en) 2010-02-12 2011-08-18 Emory University Compositions and uses of lectins
JP2012059906A (ja) * 2010-09-09 2012-03-22 Sony Corp 記憶素子、メモリ装置
FR3051192B1 (fr) * 2016-05-13 2020-12-25 Univ De Lorraine Methode de purification de proteines recombinantes par affinite basee sur l'activite lectinique du domaine crd d'une galectine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488488B2 (en) 2002-02-28 2009-02-10 Meui Seika Kaisha, Ltd. Tick chitinase
EP1479773B8 (de) * 2002-02-28 2007-02-14 Meiji Seika Kaisha Ltd. Galectin aus milben

Also Published As

Publication number Publication date
US20050106677A1 (en) 2005-05-19
EP1479773B1 (de) 2006-08-30
US8057801B2 (en) 2011-11-15
EP1479773A4 (de) 2005-07-27
AU2003211361A1 (en) 2003-09-09
US7547682B2 (en) 2009-06-16
AU2003211361B8 (en) 2008-04-03
DE60307987T2 (de) 2006-12-21
EP1479773A1 (de) 2004-11-24
JP4300117B2 (ja) 2009-07-22
WO2003072781A1 (fr) 2003-09-04
AU2003211361B2 (en) 2007-12-13
US7135552B2 (en) 2006-11-14
NZ535468A (en) 2006-08-31
US20100196407A1 (en) 2010-08-05
DE60307987T8 (de) 2007-05-03
BR0303322A (pt) 2004-12-28
JPWO2003072781A1 (ja) 2005-06-23
DE60307987D1 (de) 2006-10-12
EP1479773B8 (de) 2007-02-14
US20070021596A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
DE60211535D1 (de) Verfahren zur herstellung von 2,5-diformylfuran aus kohlenhydraten
AR041780A1 (es) Combinaciones de compuestos activos, metodo para controlar hongos, material de propagacion tratado mediante ese metodo, combinaciones funguicidas e insecticidas, uso de esas combinaciones o composiciones para controlar hongos e insectos, y procedimiento para la preparacion de esas composiciones
WO2007046006A3 (en) Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15rbeta/gamma, and hyperagonist (ilralpha sushi-il 15) fusion proteins
DE602004024542D1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
ATE448744T1 (de) Vorrichtung zur behandlung von frakturen des femur
DE122012000007I1 (de) Zusammenzetzungen und verfahren zur stabilisierungvon transthyretin und zur hemmung von transthyret infehlfaltung.
NO20040139L (no) N- (3-amino-2-hydroksy-propyl) substituerte alkylamidoforbindelser
DE50311676D1 (de) Vorrichtung zur elastischen stabilisierung von wirbelkörpern
DE60136546D1 (de) Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen
DE60214060D1 (de) Vorrichtung zur Bereitstellung von Wegbeschreibung
DE60217512D1 (de) Mattglanz freie radikale enthaltende pulverbeschichtungen
DK1689232T3 (da) Fremgangsmåde til beskyttelse af materialer
NO20052771D0 (no) Kamille/Alovera-behandlet hanske.
ATE338125T1 (de) Galectin aus milben
DE60204584D1 (de) Zusammensetzungen enthaltend eine niedrige konzentration an peroxide zur behandlung von vaginitis
EA200601220A1 (ru) Анти-trkc антитела-агонисты и способы их применения
NO20013142L (no) Substituerte (aminoiminometyl eller aminometyl)benzoheteroarylforbindelser
DE60316443D1 (de) Zusammensetzung zur köderung von blutsaugenden arthropoden und fruchtfliegen
ATE406438T1 (de) Menschliches homolog aus der familie der metalloproteasen
DE60308045D1 (de) Pflanzenextrakte aus argyrolobium roseum zur behandlung von diabetes
ATE282960T1 (de) Entomopathogenenischer pilz zur verwendung als insektizide
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen
DK1372669T3 (da) Bisphosphonatholding sammensætning til forebyggelse og/eller behandling af metaboliske knoglesygdomme, fremgangsmåde til fremstilling af sådanne sammensætninger og anvendelse deraf
BRPI0411168A (pt) composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos
EP1479697A4 (de) Zecken-chitinase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties